TGR BioSciences Pty Ltd (TGR) is located in Adelaide, Australia. Established in 2001, TGR is committed to providing innovative solutions for cell-based research applications. Our scientists have expertise in cell biology, biochemistry and immunoassay design, and have developed products and services of the highest quality, which have been used successfully in drug discovery programs around the world.
In May 2018, TGR was acquired by Sygnis AG, now called Expedeon AG following its name change. Expedeon has its main premises in Cambridge, UK, and is focussed on provision of scientific reagents and assay technologies for accelerating research.
TGR has a significant investment in its research and development, and supports its customers’ research efforts by continually providing new cellular assays for the interrogation of cellular processes that underlie disease. TGR strives to create an atmosphere of continual learning and improvement, as well as high-quality technical support to provide products of exceptional performance to our customers.
To this end, TGR underpins its core products with its patented CaptSure™ technology. This innovative antibody immobilization system provides for faster and easier immunoassays, plus the benefits of significant reductions in manufacturing costs. Further, TGR has developed CaptSure™ Multiplex for the analysis of multiple targets in a single sample. In addition to utilizing CaptSure™ in its own products, TGR works with other companies to access this technology under licensing arrangements.
TGR’s flagship immunoassay range, SureFire® Ultra, underpins a range of assay kits for analysis of cellular phosphoproteins, and are manufactured at its facility in Adelaide. SureFire Ultra kits are distributed exclusively through PerkinElmer, Inc. (USA), a global market leader in laboratory reagents. With over 100 SureFire Ultra kits currently available, SureFire Ultra assays provide an unparalleled toolbox for measuring endogenous signalling proteins in a homogeneous format.
TGR’s ELISA-ONE™ is a highly sensitive immunoassay technology that provides rapid results without all of the handling steps typical of standard ELISA applications. ELISA-ONE also brings flexibility to this platform, allowing users to measure multiple targets on a single 96-well plate, using standard plate readers. ELISA-ONE represents the next generation in ELISA technology. The ELISA-ONE technology has also been applied to the development of CaptSure™ DIY ELISA, a new product that provides the fastest and easiest ELISA development system on the market.
All TGR products, other than the SureFire range, are now available globally through our parent company, Expedeon, at the following website, www.expedeon.com. SureFire products are available from Perkin Elmer, via www.perkinelmer.com.